https://www.selleckchem.com/
Although fecal microbiota transplantation (FMT) is a recommended, clinically efficacious, and cost-effective treatment for recurrent Clostridioides difficile infection (CDI), the scale of FMT use in the United States is unknown. We developed a population-level CDI model. We estimated that 48,000 FMTs could be performed annually, preventing 32,000 CDI recurrences. Improving access to FMT could lead to tens of thousands fewer C. difficile episodes per year. Improving access to FMT could lead to tens of thousands fewer C. difficile episodes per year. Future bu